Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02544074 · ClinicalTrials.gov registry record
Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)
A clinical trial, sponsored by Ohio State University.
- Completed
- Registry status
- 69
- Enrollment target
NCT02544074 is a clinical trial that has completed, run by Ohio State University. The registered enrollment target is 69 participants.
The verdict
NCT02544074 has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- 69 participants
- Enrollment target
Study Summary
The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia. SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable forms allows it to be given in almost any setting, does not require any staff time to administer and makes it practical to rapidly screen large numbers of individuals in the community or in their home.This trial is being conducted to study the validity of SAGE in a digital format (eSAGE) for cognitive screening. The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not. Addendum: The eSAGE was previously validated in an earlier stage of this trial. It was initially designed for tablet use and the exact same test has recently been formatted for smartphone use. This addendum is being conducted to study the validity of the smartphone eSAGE compared to the tablet eSAGE for cognitive screening.
Interventions
- BEHAVIORAL neuropsychological testing
- BEHAVIORAL eSAGE testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2015-01 |
| Est. Completion | 2024-11-13 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02544074
The ClinicalTrials.gov registry entry for NCT02544074 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 69 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which neuropsychological testing is the first listed.
NCT02544074 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02544074 about?
NCT02544074 is a clinical study titled "Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)". The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia. SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable forms allows it to be given i...
What is the current status of trial NCT02544074?
This trial is currently completed. The enrollment target is 69 participants. The study started on 2015-01. Estimated completion is 2024-11-13.
What interventions are being tested in trial NCT02544074?
The interventions under investigation include: neuropsychological testing (BEHAVIORAL), eSAGE testing (BEHAVIORAL).
Who is sponsoring clinical trial NCT02544074?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.